Dr. Gleich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 N Medical Dr
Salt Lake City, UT 84132Phone+1 801-581-2955Fax+1 801-587-6346
Education & Training
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1959 - 1961
- Philadelphia General HospitalInternship, Transitional Year, 1956 - 1957
- University of Michigan Medical SchoolClass of 1956
- Boston Children’s Hospital//Boston Medical CenterFellowship, Sports Medicine (Pediatrics)
Certifications & Licensure
- MI State Medical License 1957 - Present
- NY State Medical License 1961 - Present
- UT State Medical License 2001 - 2026
- MN State Medical License 1965 - 2016
- WA State Medical License 2000 - 2003
- FL State Medical License 1973 - 1998
- PA State Medical License 1957 - 1976
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 1976
Clinical Trials
- Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema Start of enrollment: 2010 Feb 01
Publications & Presentations
PubMed
- 166 citationsLocalization of Eosinophil Granule Major Basic Protein in Chronic UrticariaMargot S. Peters, Arnold L. Schroeter, Gail M. Kephart, Gerald J. Gleich
The Journal of Investigative Dermatology. 1983-07-01 - 127 citationsLong-term safety of mepolizumab for the treatment of hypereosinophilic syndromesFlorence Roufosse, Jean Emmanuel Kahn, Gerald J. Gleich, Lawrence B. Schwartz, Anish Singh
The Journal of Allergy and Clinical Immunology. 2013-02-01 - 13 citationsAirway hypersensitivity induced by eosinophil granule-derived cationic proteins.Lu-Yuan Lee, Qihai Gu, An-Hsuan Lin, Mehdi Khosravi, Gerald J. Gleich
Pulmonary Pharmacology & Therapeutics. 2019-05-13
Journal Articles
- Clinical Communications Allergic Rhinitis and Asthma Induced by Boxelder Bug SensitizationGerald J Gleich, Jamie Zussman, ScienceDirect
- Dexpramipexole: A New Antieosinophil Drug?Gerald Gleich, MD, Blood
Press Mentions
- Why the FDA Approved an Asthma Drug to Treat Rare Blood DisordersSeptember 26th, 2020
- Mepolizumab Reduces Flares in Patients with Hypereosinophilic SyndromeNovember 19th, 2019
Grant Support
- Tmem103 In Eosinophil DevelopmentNational Institute Of Allergy And Infectious Diseases2009–2010
- Clinical Trial: Icatibant For The Treatment Of Hereditary AngioedemaNational Center For Research Resources2008
- T Cell Reactive Epitopes Of Shrimp TropomyosinNational Institute Of Allergy And Infectious Diseases2007–2008
- Standard Values Of Eosinophil-Related Parameters For Data ComparisonNational Center For Research Resources2007–2008
- The Hypereosinophilic Syndromes And MepolizumabNational Center For Research Resources2005–2008
- Icatibant For The Treatment Of Hereditary AngioedemaNational Center For Research Resources2007
- The Hypereosinophilic Syndromes And MepolizumabNational Institute Of Allergy And Infectious Diseases2004–2007
- The Hypereosinophilic Syndromes And Mepolizumab - OPEN LabelNational Center For Research Resources2005–2006
- Eosinophil Granule Proteins And Their FunctionsNational Institute Of Allergy And Infectious Diseases2002–2006
- Eosinophilia Myalgia SyndromeNational Center For Research Resources2004
- Core--Eosinophil Granule Protein LaboratoryNational Institute Of Allergy And Infectious Diseases2001–2002
- Eosinophil And Basophil Granule ProteinsNational Institute Of Allergy And Infectious Diseases2001
- Eosinophil And Basophil Granule ProteinsNational Institute Of Allergy And Infectious Diseases1997–2001
- Training Grant In Allergic DiseasesNational Institute Of Allergy And Infectious Diseases1994–2001
- Mechanisms Of Eosinophil Associated InflamationNational Institute Of Allergy And Infectious Diseases1997–2000
- Lidocaine And Sulfonylureas As Glucocorticomimetic AgentsNational Institute Of Allergy And Infectious Diseases1997–2000
- Purification &Analysis Of Primate EosinophilsNational Center For Research Resources1997
- Mechanisms Of Eosinophil-Associated InflammationNational Institute Of Allergy And Infectious Diseases1993–1996
- Functions Of EosinophilsNational Institute Of Allergy And Infectious Diseases1992–1996
- Pathogenesis Of The Eosinophilia-Myalgia SyndromeNational Institute Of Allergy And Infectious Diseases1991–1995
- Eosinophils In Human DiseaseNational Institute Of Allergy And Infectious Diseases1985–1995
- Allergic DiseasesNational Institute Of Allergy And Infectious Diseases1989–1993
- The Functions Of EosinophilsNational Institute Of Allergy And Infectious Diseases1987–1993
- Eosinophil Major Basic Protein In Human PregnancyEunice Kennedy Shriver National Institute Of Child Health &Human Development1988–1991
- Training Program In Allergic DiseasesNational Institute Of Allergy And Infectious Diseases1985–1988
- Asthma And Allergic Disease Center Program GrantNational Institute Of Allergy And Infectious Diseases1985–1987
- Immunological Sciences Study SectionCenter For Scientific Review1985–1987
- Eosinophils In Human DiseaseNational Institute Of Allergy And Infectious Diseases1986
- The Functions Of EosinophilsNational Institute Of Allergy And Infectious Diseases1985–1986
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: